The Microbiotics Company
Pharynx and Throat Care Products
Cold and sore throat
A cold or a flu-like infection is an infection of the upper respiratory tract. Symptoms such as sore throat, rhinitis, cough, hoarseness are common. Fever is also possible.
The typical course of an upper respiratory tract infection often begins as a simple viral infection. The virus attacks the pharyngeal mucosa and thus enables the penetration of inflammatory bacteria.
The main cause of bacterial throat and pharyngitis is the inflammatory bacterium Streptococcus pyogenes. If the quantity of this bacterium increases, the microbiome in the throat and pharynx is weakened. It’s getting out of balance. salvans® helps to maintain and restore balance.
The microbiome in the throat and pharynx
The human microbiome is the community of microbes (bacteria, viruses and fungi) in and on our body. This ecosystem is important for our health, also in the throat. We could not live without these microorganisms. We influence the microbiome in turn through our lifestyle and through our diet.
In a healthy state and with an intact microbiome, there is a large number of different bacteria on the pharyngeal mucosa (physicians speak of a high alpha diversity). An intact microbiome in the pharynx and throat area is an important prerequisite and protection for our health.
When there is a strong increase in pathogenic bacteria such as Streptococcus pyogenes, the diverse interaction of the bacterial world in the throat and pharynx becomes unbalanced. The mucous membrane is attacked and can no longer perform its protective function.
salvans® - active ingredient to reduce inflammatory bacteria in the throat and pharynx
With salvans® we have developed a bioactive substance that acts very specifically against the inflammation-causing bacterium Streptococcus pyogenes. salvans® reliably reduces harmful germs and thus accelerates the healing process. At the same time, it does not affect the beneficial bacteria in the throat area.
The surface of the active ingredient salvans® has a high contact affinity for the inflammatory bacterium Streptococcus pyogenes. Due to the surface structure, the active ingredient and the inflammatory germ become entangled when touching their surfaces within milliseconds. S. pyogenes is thereby intercepted and can no longer develop its inflammatory effect. The germ is removed by mechanical removal of the lumps with the saliva flow.
The active ingredient salvans® is derived from the unique strain of the lactic acid bacterium Lactobacillus crispatus DSM25988. By means of a patented microbiological high-tech process, the shells of this lactic acid bacterium are obtained for the active ingredient and optimised with regard to their binding capacity.
salvans® is protected by patent.
salvans® - Products
- Finished assembled end products
- Customized product variants
- Private label products or out-licensing
- The active ingredient salvans® Microbiotics for the production of food products
salvans® Throat lozenges
